InflaRx (IFRX) Cash from Operations (2016 - 2026)

InflaRx has disclosed Cash from Operations across 11 years of filings, most recently posting -$3.0 million for Q2 2026.

• In Q2 2026, Cash from Operations rose 65.03% year-over-year to -$3.0 million; the TTM figure through Jun 2026 stood at -$27.7 million (up 40.59% YoY), while the FY2025 annual figure was -$39.9 million, up 23.11% from the prior year.
• Cash from Operations came in at -$3.0 million for Q2 2026 at InflaRx, up from -$8.7 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of -$3.0 million in Q2 2026 to a low of -$16.2 million in Q1 2024.
• Average Cash from Operations over 5 years is -$10.0 million, with a median of -$10.9 million recorded in 2023.
• Year-over-year, Cash from Operations surged 72.82% in 2022 and plunged 119.84% in 2023.
• Over 5 years, Cash from Operations stood at -$5.3 million in 2022, then tumbled by 119.84% to -$11.7 million in 2023, then fell by 8.63% to -$12.7 million in 2024, then soared by 56.91% to -$5.5 million in 2025, then surged by 45.42% to -$3.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were -$3.0 million in Q2 2026, -$8.7 million in Q1 2026, and -$5.5 million in Q4 2025.